廣州白雲山醫藥控股股份有限公司 - 收益表 (TTM)

廣州白雲山醫藥控股股份有限公司
HK ˙ SEHK ˙ CNE100000387
HK$15.36 ↓ -0.07 (-0.45%)
2026-06-05
分享價格
收益表 (TTM)

廣州白雲山醫藥控股股份有限公司收益表顯示了一段時間內收入和支出的變化。收益表的數據包括銷售和收入、毛利、研發開支(R&D)、銷售、一般及行政開支(SG&A)、營業利潤、所得稅開支、財務成本、非營業收益、每股盈利(EPS)和已發行股份。

除以每股為單位的數字外,所有數字為1,000,000倍數。

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
收入 67,333 68,329 69,014 69,507 70,106 70,280 70,788 71,878 73,538 74,167 75,515 76,833 76,588 76,391 74,993 74,520 75,785 77,539 77,656 78,460
改變 (%) 1.48 1.00 0.71 0.86 0.25 0.72 1.54 2.31 0.85 1.82 1.74 -0.32 -0.26 -1.83 -0.63 1.70 2.31 0.15 1.04
佔收入的百分比 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
銷售成本 55,174 55,850 55,825 55,984 56,762 57,087 57,548 58,440 59,664 60,094 61,373 62,647 62,982 63,462 62,518 62,514 63,444 64,675 65,134 65,820
改變 (%) 1.22 -0.04 0.29 1.39 0.57 0.81 1.55 2.09 0.72 2.13 2.08 0.53 0.76 -1.49 -0.01 1.49 1.94 0.71 1.05
佔收入的百分比 81.94 81.74 80.89 80.55 80.97 81.23 81.30 81.30 81.13 81.03 81.27 81.54 82.23 83.08 83.37 83.89 83.72 83.41 83.87 83.89
營業毛利 12,158 12,479 13,189 13,522 13,344 13,193 13,240 13,438 13,874 14,073 14,143 14,186 13,606 12,928 12,475 12,006 12,340 12,864 12,522 12,640
改變 (%) 2.64 5.69 2.52 -1.32 -1.13 0.36 1.49 3.25 1.43 0.49 0.31 -4.09 -4.98 -3.51 -3.76 2.79 4.24 -2.66 0.94
佔收入的百分比 18.06 18.26 19.11 19.45 19.03 18.77 18.70 18.70 18.87 18.97 18.73 18.46 17.77 16.92 16.63 16.11 16.28 16.59 16.13 16.11
銷售、一般及行政費用 7,193 7,632 8,050 8,143 8,308 8,060 8,117 8,260 8,405 8,644 8,558 8,588 8,399 8,016 8,062 7,745 8,028 8,286 8,417 8,433
改變 (%) 6.09 5.48 1.16 2.02 -2.98 0.71 1.77 1.75 2.84 -1.00 0.36 -2.21 -4.55 0.56 -3.93 3.65 3.22 1.58 0.20
佔收入的百分比 10.68 11.17 11.66 11.72 11.85 11.47 11.47 11.49 11.43 11.65 11.33 11.18 10.97 10.49 10.75 10.39 10.59 10.69 10.84 10.75
研發 729 814 875 927 930 934 819 760 779 735 782 789 773 781 764 721 658 629 662 677
改變 (%) 11.60 7.52 6.03 0.29 0.46 -12.30 -7.26 2.47 -5.67 6.48 0.86 -2.05 1.09 -2.23 -5.55 -8.79 -4.40 5.19 2.26
佔收入的百分比 1.08 1.19 1.27 1.33 1.33 1.33 1.16 1.06 1.06 0.99 1.04 1.03 1.01 1.02 1.02 0.97 0.87 0.81 0.85 0.86
營運支出 63,507 64,725 65,044 65,373 66,050 66,106 66,301 67,260 68,916 69,465 70,719 71,929 72,050 72,235 71,297 70,994 72,445 73,830 74,454 75,241
改變 (%) 1.92 0.49 0.51 1.04 0.09 0.29 1.45 2.46 0.80 1.80 1.71 0.17 0.26 -1.30 -0.43 2.04 1.91 0.84 1.06
佔收入的百分比 94.32 94.73 94.25 94.05 94.21 94.06 93.66 93.58 93.72 93.66 93.65 93.62 94.08 94.56 95.07 95.27 95.59 95.22 95.88 95.90
營業收入 3,826 3,604 3,970 4,134 4,056 4,174 4,487 4,618 4,622 4,701 4,796 4,904 4,537 4,156 3,696 3,526 3,339 3,709 3,203 3,219
改變 (%) -5.80 10.17 4.12 -1.88 2.91 7.50 2.92 0.08 1.73 2.02 2.25 -7.48 -8.40 -11.08 -4.58 -5.31 11.08 -13.65 0.51
佔收入的百分比 5.68 5.27 5.75 5.95 5.79 5.94 6.34 6.42 6.28 6.34 6.35 6.38 5.92 5.44 4.93 4.73 4.41 4.78 4.12 4.10
利息花費 -380 -426 -418 -441 -422 -419 -434 -440 -452 -457 -446 -441 -434 -431 -418 -413 -409 -407 -402 -403
改變 (%) 11.97 -1.80 5.60 -4.36 -0.73 3.70 1.22 2.78 1.15 -2.39 -1.19 -1.54 -0.79 -2.90 -1.15 -1.10 -0.54 -1.25 0.45
佔收入的百分比 -0.56 -0.62 -0.61 -0.63 -0.60 -0.60 -0.61 -0.61 -0.61 -0.62 -0.59 -0.57 -0.57 -0.56 -0.56 -0.55 -0.54 -0.52 -0.52 -0.51
淨利 3,653 3,568 3,720 3,898 3,807 3,883 3,967 4,069 4,188 4,283 4,056 4,105 3,794 3,423 2,835 2,699 2,802 2,987 2,983 2,946
改變 (%) -2.34 4.26 4.79 -2.32 1.97 2.16 2.60 2.91 2.28 -5.32 1.22 -7.58 -9.77 -17.17 -4.82 3.83 6.58 -0.12 -1.26
佔收入的百分比 5.43 5.22 5.39 5.61 5.43 5.52 5.60 5.66 5.69 5.78 5.37 5.34 4.95 4.48 3.78 3.62 3.70 3.85 3.84 3.75

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:GU5 €1.65
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista